Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 The mean maximal walking distance increase from baseline in patients with peripheral arterial disease after 24 weeks of treatment with placebo (n = 239), pentoxifylline 400 mg three times daily (n = 232), or cilostazol 100 mg twice daily (n = 227). *p < 0.001 vs. pentoxifylline (84).
|
